STOCK TITAN

APN Stock Price, News & Analysis

APN NYSE

Company Description

Apeiron Capital Investment Corp. (APN) is a blank check company established with the primary goal of executing mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations. Under the leadership of Chief Executive Officer Dr. Joel Shulman, the company has navigated various business ventures and strategic decisions to maximize shareholder value.

As of August 11, 2023, Apeiron Capital Investment Corp. announced its decision to terminate the Business Combination Agreement with GIO World Health, Ltd. Due to the inability to complete an initial business combination within the required timeframe, the company will liquidate and dissolve effective August 14, 2023. This decision will lead to the redemption of all outstanding public shares at a per-share price determined by the trust account funds, excluding up to $100,000 allocated for dissolution expenses. Public shares will be deemed canceled and holders will receive their redemption amounts shortly after the termination date.

The company has instructed the trustee to liquidate the trust account, with proceeds held in a non-interest bearing account until disbursement to shareholders. Founder shares issued during the initial public offering will not be redeemed, and the company's warrants will expire worthless under the current plan.

Apeiron Capital Investment Corp. has always aimed to provide transparent and effective communication with its investors. The company’s forward-looking statements have outlined potential business combinations and financing plans, which have been subject to various market conditions and regulatory factors.

With a focus on shareholder value and diligent financial management, Apeiron Capital Investment Corp. remains committed to adhering to regulatory standards and fulfilling its obligations to its stakeholders as it transitions through the liquidation process.

Stock Performance

$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$223.6M
Market Cap
0.0
Shares outstanding

SEC Filings

No SEC filings available for APN.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Diluted EPS (TTM)
Operating Cash Flow
Net Profit Margin
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the market cap of APN (APN)?

The market cap of APN (APN) is approximately 223.6M.

What is Apeiron Capital Investment Corp. (APN)?

Apeiron Capital Investment Corp. is a blank check company focused on mergers, asset acquisitions, and similar business combinations.

Who is the CEO of Apeiron Capital Investment Corp.?

Dr. Joel Shulman is the Chief Executive Officer of Apeiron Capital Investment Corp.

Why is Apeiron Capital Investment Corp. liquidating?

The company is liquidating due to its inability to complete an initial business combination within the required timeframe.

What happens to the public shares after liquidation?

Public shares will be redeemed at a per-share price based on trust account funds and deemed canceled upon liquidation.

Will the company's warrants have any value after liquidation?

No, the company's warrants will expire worthless as per the current plan.

Do shareholders need to take any action to receive the redemption amount?

Beneficial owners of public shares held in 'street name' do not need to take any action to receive the redemption amount.

What is the expected timeline for the redemption process?

The redemption process is expected to be completed within ten business days after August 14, 2023.

Will founder shares be redeemed during the liquidation process?

No, the company's sponsor has agreed to waive redemption rights for the founder shares.

What is the purpose of the trust account liquidation?

The trust account liquidation aims to disburse funds to public shareholders in line with the company's dissolution plans.

How can I contact Apeiron Capital Investment Corp. for more information?

You can contact Dr. Joel Shulman, the CEO, via email at shulman@ershares.com or phone at (617) 279-0045.